These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37863888)

  • 41. Reveal the Heterogeneity in the Tumor Microenvironment of Pancreatic Cancer and Analyze the Differences in Prognosis and Immunotherapy Responses of Distinct Immune Subtypes.
    Wang X; Li L; Yang Y; Fan L; Ma Y; Mao F
    Front Oncol; 2022; 12():832715. PubMed ID: 35252003
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative Grading of Glioma Using Dynamic Susceptibility Contrast MRI: Relative Cerebral Blood Volume Analysis of Intra-tumoural and Peri-tumoural Tissue.
    Soliman RK; Gamal SA; Essa AA; Othman MH
    Clin Neurol Neurosurg; 2018 Apr; 167():86-92. PubMed ID: 29471287
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment.
    Desmedt C; Majjaj S; Kheddoumi N; Singhal SK; Haibe-Kains B; El Ouriaghli F; Chaboteaux C; Michiels S; Lallemand F; Journe F; Duvillier H; Loi S; Quackenbush J; Dekoninck S; Blanpain C; Lagneaux L; Houhou N; Delorenzi M; Larsimont D; Piccart M; Sotiriou C
    Clin Cancer Res; 2012 Feb; 18(4):1004-14. PubMed ID: 22235100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers.
    Witkiewicz AK; Kline J; Queenan M; Brody JR; Tsirigos A; Bilal E; Pavlides S; Ertel A; Sotgia F; Lisanti MP
    Cell Cycle; 2011 Jun; 10(11):1794-809. PubMed ID: 21521946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Yes-associated protein (YAP) is differentially expressed in tumor and stroma according to the molecular subtype of breast cancer.
    Kim SK; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(6):3224-34. PubMed ID: 25031743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contemporary evaluation of estrogen receptor and progesterone receptor expression in breast cancer-associated stroma.
    Moreno GA; Molina MI; Eastwood D; Auer PL; Jorns JM
    Breast Cancer Res Treat; 2022 Dec; 196(3):453-461. PubMed ID: 36208382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High Intratumoral Stromal Content Defines Reactive Breast Cancer as a Low-risk Breast Cancer Subtype.
    Dennison JB; Shahmoradgoli M; Liu W; Ju Z; Meric-Bernstam F; Perou CM; Sahin AA; Welm A; Oesterreich S; Sikora MJ; Brown RE; Mills GB
    Clin Cancer Res; 2016 Oct; 22(20):5068-5078. PubMed ID: 27172895
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Image-Guided Peri-Tumoral Radiofrequency Hyperthermia-Enhanced Direct Chemo-Destruction of Hepatic Tumor Margins.
    Chen M; Zhang F; Song J; Weng Q; Li P; Li Q; Qian K; Ji H; Pietrini S; Ji J; Yang X
    Front Oncol; 2021; 11():593996. PubMed ID: 34235070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Upregulation of Nox4 induces a pro-survival Nrf2 response in cancer-associated fibroblasts that promotes tumorigenesis and metastasis, in part via Birc5 induction.
    Mir S; Ormsbee Golden BD; Griess BJ; Vengoji R; Tom E; Kosmacek EA; Oberley-Deegan RE; Talmon GA; Band V; Teoh-Fitzgerald ML
    Breast Cancer Res; 2022 Jul; 24(1):48. PubMed ID: 35836253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscape.
    Xie P; An R; Yu S; He J; Zhang H
    J Transl Med; 2021 Sep; 19(1):398. PubMed ID: 34544424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumoral heterogeneity of breast cancer.
    Roulot A; Héquet D; Guinebretière JM; Vincent-Salomon A; Lerebours F; Dubot C; Rouzier R
    Ann Biol Clin (Paris); 2016 Dec; 74(6):653-660. PubMed ID: 27848916
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deciphering HER2 Breast Cancer Disease: Biological and Clinical Implications.
    Godoy-Ortiz A; Sanchez-Muñoz A; Chica Parrado MR; Álvarez M; Ribelles N; Rueda Dominguez A; Alba E
    Front Oncol; 2019; 9():1124. PubMed ID: 31737566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterisation of the Stromal Microenvironment in Lobular Breast Cancer.
    Gómez-Cuadrado L; Bullock E; Mabruk Z; Zhao H; Souleimanova M; Noer PR; Turnbull AK; Oxvig C; Bertos N; Byron A; Dixon JM; Park M; Haider S; Natrajan R; Sims AH; Brunton VG
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues.
    Gabrielson M; Chiesa F; Paulsson J; Strell C; Behmer C; Rönnow K; Czene K; Östman A; Hall P
    Breast Cancer Res Treat; 2016 Jul; 158(2):253-61. PubMed ID: 27349429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cellular heterogeneity map of diverse immune and stromal phenotypes within breast tumor microenvironment.
    Li Y; Chen Z; Wu L; Ye J; Tao W
    PeerJ; 2020; 8():e9478. PubMed ID: 32728493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior.
    Perez-Villamil B; Romera-Lopez A; Hernandez-Prieto S; Lopez-Campos G; Calles A; Lopez-Asenjo JA; Sanz-Ortega J; Fernandez-Perez C; Sastre J; Alfonso R; Caldes T; Martin-Sanchez F; Diaz-Rubio E
    BMC Cancer; 2012 Jun; 12():260. PubMed ID: 22712570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer.
    Mony JT; Schuchert MJ
    Front Immunol; 2018; 9():2298. PubMed ID: 30374348
    [No Abstract]   [Full Text] [Related]  

  • 58. Microarray Analysis for Differentially Expressed Genes Between Stromal and Epithelial Cells in Development and Metastasis of Invasive Breast Cancer.
    Wang R; Fu L; Li J; Zhao D; Zhao Y; Yin L
    J Comput Biol; 2020 Dec; 27(12):1631-1643. PubMed ID: 32429691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors.
    Parise CA; Caggiano V
    Breast Cancer Res Treat; 2017 Oct; 165(3):743-750. PubMed ID: 28689363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
    Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
    J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.